Drug abuse is common in sport and many athletes take large doses of anabolic-androgenic steroids. It has been suspected for some time that these drugs may have psychological effects. In the past, attempts have been made to demonstrate beneficial psychotropic effects. Recent literature suggests a high incidence of psychiatric morbidity in anabolic-androgenic steroid abusers. In addition, some anabolic-androgenic steroid abusers have been noted to exhibit addictive behaviour. Further study of this unique group who self-administer massive doses of synthetic male hormones is warranted.
Bahrke M.S., Yesalis C.E., Wright J.E. (1990b) Psychological and behavioural effects of endogenous testosterone levels and anabolic-androgenic steroids among males: a reviewNew Zealand Sports-Med10: 303-307
6.
Barker S. (1987) Oxymethalone and aggressionBr J Psychiatr151: 564
7.
Beumont P J V, Bancroft J H J, Beardwood C.J. (1972) Behavioural changes after treatment with testosterone: a case reportPsychol Med2: 70-72
Brower K.J., Eliopulos G.A.,Blow F.C. , Catlin D.H., Beresford T.P. (1990) Evidence for physical and psychological dependence on anabolic-androgenic steroids in eight weightliftersAm J Psychiatr147: 510-512
11.
Burkett L.N., Falduto M.T. (1984) Steroid use by athletes in a metropolitan areaPhysician Sports Med12: 69-74
12.
Buss A.H. (1961) The psychology of aggression. John Wiley, Chichester.
13.
Choi P Y L, Parrott A.C., Cowan D. (1989) Adverse behavioural effects of anabolic steroids in athletes: a brief reviewClin Sports Med1: 183-187
14.
Choi P Y L, Parrott A.C., Cowan D. (1990) High dose anabolic-steroids in strength athletes: effects upon hostility and aggressionHuman Psychopharmacol5: 349-356
15.
Cohen J.C., Noakes T.D., Spinnler Benade A.J. (1988) Hypercholesterolaemia in male powerlifters using anabolic-androgenic steroidsPhysician Sports Med16: 49-56
16.
Davidson J.M., Carnargo C.A., Smith E.R. (1979) Effects of androgens on sexual behaviour in hypogonadal menJ Clin Endocrinol Metab48: 955-958
17.
Evans R.M., Arriza J.L. (1989) A molecular framework for the action of glucocorticoid hormones in the nervous systemNeuron2: 1105-1112
Goldman R. (1984) Death in the locker roomIcarus Press Inc., South Bend, IN.
20.
Hallagan J.B., Hallagan L.F., Snyder M.B. (1989) Anabolic-androgenic steroid use by athletesNew Engl J Med321: 1042-1043
21.
Haupt H.A., Rovere G.D. (1984) Anabolic steroids: a review of the literatureAm J Sports Med12: 469-484
22.
Herrmann W.M., Beach R.C. (1976) Psychotropic effects of androgens: a review of clinical observations and new human experimental findingsPharmakopsychologie9: 205-219
23.
Itil T.M. (1976) The neurophysiological models in the development of psychotropic hormones In Itil T M, Laudahn G, Herrmann W (eds), Psychotropic action of hormones.Spectrum Publishing , New York, NY, pp. 53-77
24.
Itil T.M., Cora R., Akpinar S., Herrmann W.M., Patterson C. (1974) Psychotropic action of sex hormones: computerised EEG in establishing the immediate CNS effects of steroid hormonesCurr Ther Res15: 1147-1170
25.
Itil T.M., Michael S.T., Shapiro D.M., Itil K.Z. (1984) The effects of mesterolone, a male sex hormone in depressed patients (a double blind controlled study)Methods Findings Exp Clin Pharmacol6 : 331-337
26.
Itil T.M., Michael S.T., Soldatos C. (1979) Androgens as antidepressantsPsychopharmacol Bull15: 31-33
27.
Kashkin K.B., Kleber H.D. (1989) Hooked on hormones? An anabolic steroid addiction hypothesisJ Am Med Assoc262: 3166-3170
28.
Kibble M.W., Ross M.B. (1987) Adverse effects of anabolic steroids in athlethesClin Pharm6: 686-692
29.
Kochakian C.D. (1990) The steroids in sports problem. Anabolic Steroid Abuse, NIDA Research Monograph, National Institute on Drug Abuse, Rockville, MD
30.
Luisi M., Franchi F. (1980) A double-blind group comparative study of testosterone undecanoate and mesterolone in hypogonadal patientsJ Endocrinol Invest3: 305-308
31.
McEwen B.S. (1991) Non-genomic and genomic effects of steroids on neural activityTrends Pharmacol Sci12: 141-147
32.
Moore D.D. (1989) Promiscuous behaviour in the steroid hormone receptor superfamilyTrends Neurosci12: 165-168
33.
Moss D.C. (1988) And now the steroid defense?Am Bar Assoc J Oct 1 p. 22.
34.
O'Carroll R., Bancroft J. (1984) Testosterone therapy for low sexual interest and erectile dysfunction in men: a controlled studyBr J Psychiatr145: 146-151
35.
O'Carroll R., Bancroft J. (1985) Androgens and aggression in man: a controlled case studyAggressive Behav11 : 1-7
36.
Pope H.G., Katz D.L. (1988) Affective and psychotic symptoms associated with anabolic steroid useAm J Psychiatr145: 487-490
37.
Pope H.G., Katz D.L. (1990) Homicide and near-homicide by anabolic steroid usersJ Clin Psychiatr51: 28-31
38.
Rosenweig S. (1978) Rosenweig picture frustration test study manualRana House, St Louis, MO.
39.
Salmimies P., Kockott G., Pirke K.M., Vogt H.J., Schill W.B. (1982) Effects of testosterone replacement on sexual behaviour in hypogonadal menArch Sex Behav11: 345-353
40.
Skakkaebaek N.E., Bancroft J., Davidson D., Warner P. (1981) Androgen replacement with oral testosterone in hypogonadal men: a double-blind controlled studyClin Endocrinol14: 49-61
41.
Spitzer R.L., Williams J B W, Gibbon M. (1987) Structured clinical interview for DSM-III-RNew York State Psychiatric Institute, Biometrics Research. New York.
42.
Taylor W.N. (1986) Hormonal manipulation: a new era of monstrous athletesMcFarland and Co. Publishers, Jefferson, NC.
43.
Tennant F., Black D.L., Voy R.O. (1988) Anabolic steroid dependence with opioid-features (Letter)New Engl J Med319: 578
44.
Vogel W., Klaiber E.L., Broverman D.M. (1985) A comparison of the antidepressant effects of a synthetic androgen (mesterolone) and amitriptyline in depressed menJ Clin Psychiatr46: 6-8
Wilson I.C., Prange J.R., Lara P.P. (1974) Methyl testosterone with imipramine in men: Conversion of depression to paranoid reactionAm J Psychiatr131: 21-24
47.
Wilson J. (1988) Androgen abuse by athletesEndocrine Rev9:181-199
48.
Yesalis C.E., Streit A.L., Vicary J.R. (1989) Anabolic steroid use: indications of habituation among adolescentsJ Drug Education19: 103-116